Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03693846
Title Nivolumab and Ipilimumab in Mucinous Colorectal and Appendiceal Tumors
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Abramson Cancer Center of the University of Pennsylvania
Indications

rectum mucinous adenocarcinoma

colon mucinous adenocarcinoma

appendix adenocarcinoma

Therapies

Ipilimumab + Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.